You just read:

Phase 1b Study of Investigational Treatment Venetoclax with Rituximab Shows Clinical Response in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia

News provided by

AbbVie Inc.

12 Jun, 2015, 07:30 BST